Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists ...

June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...

People take antipsychotics to treat schizophrenia and other mental health conditions. Your doctor will work with you to monitor your side effects and dosing schedule. Over the past few decades, access ...

High doses of a second-generation antipsychotic are associated with a significantly increased risk for death in young adults, adding to long-standing safety concerns regarding the use of higher doses ...

Antipsychotic medication is used in schizophrenia, severe depression, elation (in bipolar disorder), and other conditions. These medications offer many benefits provided they are used with care and ...

Second-Generation Antipsychotic Drugs This table lists the atypical antipsychotics. For a story on the lessons of the CATIE trial, click here. For a table of first-generation drugs, click here. For a ...

Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits. Teva Pharmaceuticals has announced positive ...